Stephen B. Wilton
Advanced in Transient Ischemic Attack (TIA)

Stephen B. Wilton

Calgary, AB, CA 
Advanced in Transient Ischemic Attack (TIA)
Calgary, AB, CA 
OverviewLocationsClinical Research

Overview

Stephen Wilton practices in Calgary, Canada. Mr. Wilton is rated as an Advanced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Arrhythmias, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 180 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

Calgary, AB, Canada
Other Locations
Calgary, Canada
Halifax, NS, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Enrollment Status: Terminated
Publish Date: November 05, 2024
Intervention Type: Drug, Device
Study Phase: Phase 3
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Enrollment Status: Terminated
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Etripamil
Study Phase: Phase 3
Carvedilol for Prevention of Paroxysmal Atrial Fibrillation
Carvedilol for Prevention of Paroxysmal Atrial Fibrillation
Enrollment Status: Unknown
Publish Date: May 27, 2022
Intervention Type: Drug
Study Phase: Not Applicable
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
Enrollment Status: Completed
Publish Date: October 21, 2021
Intervention Type: Other, Procedure
Study Phase: Not Applicable
View 3 Less Clinical Trials

180 Total Publications

Disparities in Access to Vascular Stroke Imaging and Carotid Revascularization: A Population Study.
Disparities in Access to Vascular Stroke Imaging and Carotid Revascularization: A Population Study.
Journal: Journal of the American Heart Association
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wilton's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile